The Thoracodorsal Artery Perforator Flap: A Powerful Tool in Breast Reconstruction

医学 血清瘤 乳房再造术 脂肪坏死 外科 胸背动脉 血肿 乳房切除术 乳腺癌 回顾性队列研究 蜂窝织炎 自由襟翼 癌症 并发症 内科学
作者
Christopher Homsy,Taylor Theunissen,Alireza Sadeghi
出处
期刊:Plastic and Reconstructive Surgery [Lippincott Williams & Wilkins]
卷期号:150 (4): 755-761 被引量:17
标识
DOI:10.1097/prs.0000000000009576
摘要

BACKGROUND: Perforator flap use in breast cancer reconstruction has evolved significantly in the last decade. The authors reviewed their experience and evaluated thoracodorsal artery perforator (TDAP) flap outcomes in breast reconstruction. METHODS: A retrospective chart review was conducted of all women undergoing breast reconstruction between 2012 and 2018. Included were patients who underwent a mastectomy (unilateral or bilateral) with immediate reconstruction or requiring a revision reconstruction with a TDAP flap. Reconstruction for nonmalignant causes were excluded. Patient demographics, risk factors, indications, operative details, and complications were reviewed. Major (partial or total flap necrosis, hematoma, and wound breakdown requiring operative management) and minor (cellulitis, seroma, and minor wound breakdown managed with local wound care) complications were recorded. RESULTS: A total of 138 charts were reviewed for the years 2012 and 2018, and 126 patients met inclusion criteria. Mean patient age was 52.1 years. Mean patient body mass index was 29.1 kg/m 2 . A total of 174 TDAP flaps were performed. The success rate was 98.3 percent. There were three flap losses (all partial). Operable fat necrosis rate was 3 percent. Donor-site morbidity was low at a rate of 1.2 percent. There was no difference in complications between patients who had a history of radiation therapy and those who did not (16.7 and 18.6 percent, respectively; p = 0.829). CONCLUSIONS: This study is the largest series in the literature that highlights the utility of the TDAP flap in breast reconstruction. This flap is a powerful tool that should be considered in patients for whom other reconstructive options have been exhausted or unavailable. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大方树叶发布了新的文献求助10
刚刚
刚刚
c源完成签到,获得积分20
刚刚
wangtianwen完成签到 ,获得积分10
1秒前
GG发布了新的文献求助10
1秒前
居居子完成签到,获得积分10
1秒前
Simon关注了科研通微信公众号
1秒前
LpmxRk发布了新的文献求助10
1秒前
1秒前
A晨发布了新的文献求助10
2秒前
俏皮元珊完成签到 ,获得积分10
2秒前
zhang005on完成签到,获得积分10
2秒前
咸鱼梦想家完成签到,获得积分10
2秒前
充电宝的应助被Pepsi采纳,获得10
3秒前
3秒前
wsh完成签到,获得积分10
3秒前
tuo完成签到,获得积分10
4秒前
Eraser完成签到,获得积分10
4秒前
4秒前
走啊发布了新的文献求助10
4秒前
gugo完成签到,获得积分10
5秒前
xnys完成签到,获得积分10
5秒前
yzm发布了新的文献求助10
6秒前
6秒前
Sledge的应助被山居月采纳,获得10
6秒前
6秒前
思源的应助被ykk采纳,获得10
7秒前
张清泉完成签到,获得积分20
7秒前
噜噜噜完成签到,获得积分10
7秒前
8秒前
zhangj696完成签到,获得积分10
8秒前
nanoyy完成签到,获得积分10
8秒前
自由灵安发布了新的文献求助10
10秒前
10秒前
jerry完成签到,获得积分20
10秒前
10秒前
GG完成签到,获得积分10
10秒前
MaxDYi完成签到,获得积分10
11秒前
Frank发布了新的文献求助10
11秒前
chao发布了新的文献求助10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Modern Artificial Intelligence 1000
Особенности технологий и методов информационно-психологических войн СССР с Великобританией и США в период 1939-1953 гг 1000
Das Matthäusevangelium: Kapitel 1:1–17 1000
IRTSD: Open-Source Data and Toolset for Electromagnetic Transient Analysis of Disturbances and IBR Control Malfunctions in Transmission Systems 1000
Entre Praga y Madrid : los contactos checoslovaco-españoles (1948-1977) 600
A REVIEW OF THE V-22 DYNAMICS VALIDATION PROGRAM 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8130999
求助须知:如何正确求助?哪些是违规求助? 9533315
关于积分的说明 21601348
捐赠科研通 7713144
什么是DOI,文献DOI怎么找? 3418328
关于科研通互助平台的介绍 2543979
邀请新用户注册赠送积分活动 2459666